Related Experiment Videos
Platelet [3H]-imipramine binding is not modified in Alzheimer's disease
A M Galzin1, P Davous, M Roudier
1Laboratoires d'Etudes et de Recherches Synthélabo (L.E.R.S.), Paris, France.
Psychiatry Research
|June 1, 1989
Abstract:
Platelet [3H]-imipramine binding was studied in patients with Alzheimer's disease and control subjects matched to the patients for age and sex. There were no differences in the binding parameters of [3H]-imipramine on platelet membranes from patients with Alzheimer's disease, when compared with the control group. These results suggest that [3H]-imipramine binding could be a useful tool to discriminate between demented and depressive patients in elderly populations.